Advertisement

Topics

Sanofi Pasteur and March of Dimes Company Profile

17:03 EST 22nd February 2017 | BioPortfolio

March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit www.marchofdimes.com or www.nacersano.org.


News Articles [1364 Associated News Articles listed on BioPortfolio]

Sanofi Pasteur and MSD end vaccines joint venture

Sanofi Pasteur and MSD have officially ended their European vaccines joint venture, which had been in place for more than two decades. The companies announced they were to end the Sanofi Pasteur MSD ...

Sanofi Pasteur, Merck & Co end joint vaccines business in Europe

Sanofi and its vaccines global business unit Sanofi Pasteur confirmed the end of their vaccine joint-venture with MSD (known as Merck & Co., in the United States and Canada), Sanofi Pasteur MSD...

BRIEF-Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe

* Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Paste...

Sanofi Pasteur ends vaccine JV with MSD

Sanofi Pasteur has ended its vaccine joint venture (JV) with MSD (known as Merck & Co in the US and Canada), Sanofi Pasteur MSD (SPMSD).

Sanofi: BARDA Grants $43.2 Million USD To Sanofi Pasteur For Zika

PARIS (dpa-AFX) - Sanofi and its vaccines global business unit Sanofi Pasteur announced today that the Biomedical Advanced Research and Development Authority or BARDA within the Office of the Assi...

Sanofi Pasteur, Fiocruz, and WRAIR link up for Zika vaccine research

French pharma major Sanofi and its vaccines global business unit Sanofi Pasteur have agreed to principles…

Sanofi: Sanofi Pasteur and MSD end joint vaccines business in Europe

Sanofi Pasteur and MSD end joint vaccines business in Europe Paris, France - January 2, 2017 - Sanofi (http://en.sanofi.com/index.aspx) and its vaccines global business unit Sanofi Pasteur (http:/...

Sanofi, MSD successfully terminate vaccines JV

Sanofi Pasteur and MSD have now completed the takedown of their vaccines joint venture Sanofi Pasteur MSD, ending a collaboration that has spanned more than two decades.

Drugs and Medications [59 Associated Drugs and Medications listed on BioPortfolio]

Citranatal [Mission Pharmacal Company]

CitraNatalB-CalmRx Prenatal Vitamin with two 25 mg each Vitamin B tablets

Citranatal harmony [MISSION PHARMACAL COMPANY]

CitraNatal Harmony Rx Prenatal Vitamin Gel Cap

Citranatal assure [Mission Pharmacal Company]

CitraNatalAssure Rx Prenatal Vitamin Tablet and 300 mg DHA Capsule

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Hiprex(methenamine hippurate tablets usp) [sanofi-aventis U.S. LLC]

HIPREX(methenamine hippurate tablets USP)

PubMed Articles [200 Associated PubMed Articles listed on BioPortfolio]

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.

In 1980, human diploid cell vaccine (HDCV, Imovax Rabies, Sanofi Pasteur), was licensed for use in the United States.

Safety and immunogenicity of three seasonal trivalent influenza vaccines in the Chinese military.

Influenza, caused by the influenza virus, is a contagious acute viral respiratory disease with a high incidence rate and wide and rapid spread. Influenza-related morbidity, mortality, and hospitalizat...

Comparing the Incidence Of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel And the Generic Formulations.

Studies have raised concern about the safety of generic compared with branded drugs. Febrile neutropenia (FN) resulting in hospital admission was compared between the branded docetaxel (Taxotere®, Sa...

The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

With approximately 3 billion people at risk of acquiring the infection, dengue fever is now considered the most important mosquito-borne viral disease in the world, with 390 million dengue infections ...

Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015.

 A unit of the European Mobile Laboratory (EMLab) consortium was deployed to the Ebola virus disease (EVD) treatment unit in Guéckédou, Guinea, from March 2014 through March 2015.

Clinical Trials [168 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Phase III, open, mono-center study in 177 infants who received a dose of Hep B vaccine at birth or within 1 month after birth. Infants will receive Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T c...

Companies [288 Associated Companies listed on BioPortfolio]

Sanofi Pasteur and March of Dimes

March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies...

March of Dimes and Sanofi Pasteur

March of Dimes and Sanofi Pasteur Inc.

sanofi pasteur and The March of Dimes

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

More Information about "Sanofi Pasteur and March of Dimes" on BioPortfolio

We have published hundreds of Sanofi Pasteur and March of Dimes news stories on BioPortfolio along with dozens of Sanofi Pasteur and March of Dimes Clinical Trials and PubMed Articles about Sanofi Pasteur and March of Dimes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi Pasteur and March of Dimes Companies in our database. You can also find out about relevant Sanofi Pasteur and March of Dimes Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record